Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Johnson

Showing results (441-450 of 540) with videos related to

Pageof 54
Sort By:
AIDS (London, England)|May 16, 1998
Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitisE F Bowen, V C Emery, P Wilson, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
Journal of Clinical Microbiology|October 8, 1997
Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patientsG Fabio, S N Knight, I M Kidd, et al.
Vaccine|March 4, 2000
Protection of pigs against classical swine fever with DNA-delivered gp55M E Andrew, C J Morrissy, C Lenghaus, et al.
Human Genetics|December 1, 1991
Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophyK M Bushby, N J Cleghorn, A Curtis, et al.
HIV Medicine|December 12, 2001
Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 yearsS Madge, A Mocroft, D Wilson, et al.
AIDS (London, England)|May 1, 1993
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineagesG Janossy, N Borthwick, R Lomnitzer, et al.
Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patientsC Herzmann, Z Cuthbertson, L Fosdick, et al.
AIDS (London, England)|April 1, 1994
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cellsN J Borthwick, M Bofill, W M Gombert, et al.
Pageof 54

Showing results (441-450 of 540) with videos related to

Sort By:
Pageof 54
AIDS (London, England)|May 16, 1998
Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitisE F Bowen, V C Emery, P Wilson, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
Journal of Clinical Microbiology|October 8, 1997
Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patientsG Fabio, S N Knight, I M Kidd, et al.
Vaccine|March 4, 2000
Protection of pigs against classical swine fever with DNA-delivered gp55M E Andrew, C J Morrissy, C Lenghaus, et al.
Human Genetics|December 1, 1991
Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophyK M Bushby, N J Cleghorn, A Curtis, et al.
HIV Medicine|December 12, 2001
Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 yearsS Madge, A Mocroft, D Wilson, et al.
AIDS (London, England)|May 1, 1993
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineagesG Janossy, N Borthwick, R Lomnitzer, et al.
Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patientsC Herzmann, Z Cuthbertson, L Fosdick, et al.
AIDS (London, England)|April 1, 1994
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cellsN J Borthwick, M Bofill, W M Gombert, et al.
Pageof 54